JP2024505072A5 - - Google Patents
Info
- Publication number
- JP2024505072A5 JP2024505072A5 JP2023545996A JP2023545996A JP2024505072A5 JP 2024505072 A5 JP2024505072 A5 JP 2024505072A5 JP 2023545996 A JP2023545996 A JP 2023545996A JP 2023545996 A JP2023545996 A JP 2023545996A JP 2024505072 A5 JP2024505072 A5 JP 2024505072A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- polypeptide
- constant domain
- canid
- section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163142774P | 2021-01-28 | 2021-01-28 | |
| US63/142,774 | 2021-01-28 | ||
| PCT/US2022/014146 WO2022165067A2 (en) | 2021-01-28 | 2022-01-27 | Mutations in canine antibody constant regions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024505072A JP2024505072A (ja) | 2024-02-02 |
| JP2024505072A5 true JP2024505072A5 (https=) | 2025-01-24 |
Family
ID=80786846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545996A Pending JP2024505072A (ja) | 2021-01-28 | 2022-01-27 | イヌ科動物抗体の定常領域における変異 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240059777A1 (https=) |
| EP (2) | EP4284825A2 (https=) |
| JP (1) | JP2024505072A (https=) |
| KR (1) | KR20230136604A (https=) |
| CN (1) | CN116802205A (https=) |
| AU (1) | AU2022214843A1 (https=) |
| CA (1) | CA3207285A1 (https=) |
| CL (2) | CL2023002202A1 (https=) |
| CO (1) | CO2023009994A2 (https=) |
| EC (1) | ECSP23057156A (https=) |
| IL (1) | IL304522A (https=) |
| MX (1) | MX2023008785A (https=) |
| PE (1) | PE20231919A1 (https=) |
| TW (1) | TW202246318A (https=) |
| WO (1) | WO2022165067A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115996949A (zh) * | 2020-04-17 | 2023-04-21 | 硕腾服务有限责任公司 | 犬抗体变异体 |
| EP4284825A2 (en) | 2021-01-28 | 2023-12-06 | Zoetis Services LLC | Mutations in canine antibody constant regions |
| JP2025529206A (ja) * | 2022-09-02 | 2025-09-04 | ゾエティス・サービシーズ・エルエルシー | 豚抗体変異体 |
| CN121574951B (zh) * | 2026-01-27 | 2026-04-28 | 金发科技股份有限公司 | 一种苹果酸脱氢酶、含有其的工程化库德里亚兹毕赤酵母及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5698762A (en) | 1994-12-09 | 1997-12-16 | Dauerman; Leonard | Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons |
| US20030031671A1 (en) | 2001-08-01 | 2003-02-13 | Sydney Welt | Methods of treating colon cancer utilizing tumor-specific antibodies |
| AU2005285347A1 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| AU2005304624B2 (en) | 2004-11-12 | 2010-10-07 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| US20200181258A1 (en) * | 2016-10-17 | 2020-06-11 | Vetoquinol Sa | Modified antibody constant region |
| US20210388053A1 (en) * | 2018-10-18 | 2021-12-16 | Kindred Biosciences, Inc. | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use |
| CN113544153B (zh) * | 2019-01-03 | 2024-12-10 | 因外泰克斯公司 | 用于增加治疗剂在犬中的半衰期的组合物及使用方法 |
| EP4284825A2 (en) | 2021-01-28 | 2023-12-06 | Zoetis Services LLC | Mutations in canine antibody constant regions |
-
2022
- 2022-01-27 EP EP22704666.1A patent/EP4284825A2/en active Pending
- 2022-01-27 WO PCT/US2022/014146 patent/WO2022165067A2/en not_active Ceased
- 2022-01-27 JP JP2023545996A patent/JP2024505072A/ja active Pending
- 2022-01-27 CA CA3207285A patent/CA3207285A1/en active Pending
- 2022-01-27 PE PE2023002227A patent/PE20231919A1/es unknown
- 2022-01-27 MX MX2023008785A patent/MX2023008785A/es unknown
- 2022-01-27 US US18/270,062 patent/US20240059777A1/en active Pending
- 2022-01-27 CN CN202280010912.XA patent/CN116802205A/zh active Pending
- 2022-01-27 AU AU2022214843A patent/AU2022214843A1/en active Pending
- 2022-01-27 KR KR1020237025434A patent/KR20230136604A/ko active Pending
- 2022-01-27 EP EP24210430.5A patent/EP4512416A3/en active Pending
- 2022-01-28 TW TW111104187A patent/TW202246318A/zh unknown
-
2023
- 2023-07-17 IL IL304522A patent/IL304522A/en unknown
- 2023-07-26 CL CL2023002202A patent/CL2023002202A1/es unknown
- 2023-07-27 CO CONC2023/0009994A patent/CO2023009994A2/es unknown
- 2023-07-27 EC ECSENADI202357156A patent/ECSP23057156A/es unknown
-
2024
- 2024-05-24 CL CL2024001562A patent/CL2024001562A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024505072A5 (https=) | ||
| AU2016223095B2 (en) | Antibodies to tau and uses thereof | |
| TWI585104B (zh) | 基於vl和vhh可變區衍生物的高親和力抗聚集抗體 | |
| JP2021530229A5 (https=) | ||
| JP2023522029A5 (https=) | ||
| CN114437212B (zh) | 抗人胸腺基质淋巴细胞生成素抗体及其制备方法和应用 | |
| JP2023515260A (ja) | 抗ヒトインターロイキン－４受容体α抗体及びその調製方法並びに使用 | |
| JP2024059791A (ja) | 補体関連疾患のための融合タンパク質構築物 | |
| RU2007129676A (ru) | Антитела к рецептору альфа 1 il-13 и их применение | |
| CN101986784A (zh) | 基因工程tslpr抗体 | |
| JP2024516595A5 (https=) | ||
| WO2017015783A1 (en) | Humanized anti-cd19 antibody and use thereof | |
| RU2019123112A (ru) | Анти-il-5 антитела | |
| CN107074963A (zh) | 抑制血管内皮脂肪酶的酶活性的人源化单克隆抗体 | |
| US20100297135A1 (en) | Epitope for neutralizing antibodies | |
| WO2023118241A1 (en) | Anti-canine interleukine-31-receptor a (il-31ra) antibodies and the uses thereof | |
| CN115215937B (zh) | 抗人masp-2抗体及其制备方法和应用 | |
| JP2022545925A (ja) | 抗ｔｆｐｉモノクローナル抗体 | |
| EP4644414A1 (en) | Monoclonal antibody against capsid proteins of multiple aav serotypes, preparation method therefor, and use thereof | |
| WO2024076785A2 (en) | Anti-ige antibodies | |
| AU2018423921B2 (en) | Anti-human interleukin 17A monoclonal antibody and application thereof | |
| CN115551538A (zh) | 干扰IL-1β受体信号转导的药剂 | |
| RU2025105731A (ru) | Мутанты антител свиных | |
| RU2025102187A (ru) | Мутанты бычьих антител | |
| JP3773556B2 (ja) | 抗アレルギー剤 |